Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Non-Small Cell)
Study Phase
Phase 3
Study Completion Date
January 2011
NCT00532155Uploaded 04-28-2015
Available for Download
PDS UID: LungNo_SanofiU_2007_133
A Multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients Treated With Second-Line Docetaxel After Failure of One Platinum Based Therapy for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
Files:
PROTOCOLsanofi_AVE0005_efc10261_protocol_redacted.pdf
CRFsanofi_AVE0005_efc10261_crf_redacted.pdf
DATA DICTIONARYsanofi_ave0005_efc10261_data_definition.xls
DATA (COMPARATOR ARM)sanofi_AVE0005_EFC10261_datasets_and readme.zip